Answers are grounded in this paper and cite their sources.
Baseline CD4 testing rates declined from 73% to 21% between 2013 and 2018 with adoption of "Treat All" in Uganda. Advanced human immunodeficiency virus (HIV) disease (CD4 count < 200 cells/µL) remained common (24% of those tested in 2018, 83% of whom had World Health Organization stage I/II disease). Despite frequent presentation with advanced HIV disease, CD4 testing has declined dramatically.
No takes yet. Share an insight, caveat, or question.
Nasuuna et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: